Enhanced pre-wetted intermittent catheter with lubricious coating

Information

  • Patent Grant
  • 10518000
  • Patent Number
    10,518,000
  • Date Filed
    Friday, June 30, 2017
    6 years ago
  • Date Issued
    Tuesday, December 31, 2019
    4 years ago
Abstract
The present disclosure relates to a packaged urinary catheter assembly and method of making and using the packaged urinary catheter assembly. The urinary catheter assembly includes a urinary catheter having a proximal end and a distal end. The distal end includes at least one aperture for receiving fluid from a patient. The urinary catheter is contained within a sleeve having a length, a width, and a size configured to receive the catheter. According to one embodiment, the urinary catheter and the sleeve may be arranged in a helical coil. The outer surface of the urinary catheter may have a lubricious and/or an antimicrobial coating.
Description
BACKGROUND

Intermittent catheters are generally catheters or tubes having a rounded tip connected to a distal end that is inserted into the bladder of a patient or user, and a molded funnel connected to a proximal end that remains outside the body of the patient or user. These types of catheters are typically utilized on a temporary basis to remove urine from the bladder of a patient or user. The distal tip may include slots or openings on the shaft to facilitate drainage of urine therefrom once the tip is positioned inside the bladder. Pre-wetted intermittent catheters are intermittent catheters having a highly lubricious coating on an outer surface thereof, which are packaged or otherwise brought into contact with fluid in order to provide a catheter with a slippery outer surface to facilitate insertion into the patient or user.


Intermittent catheters are well-known in the art, and include those disclosed in U.S. Pat. Nos. 5,895,374; 6,059,107; 6,634,498; 7,311,698; 6,849,070, 7,615,045; 6,736,805; 7,087,048; 7,380,658; and 6,355,004, the disclosures of which are all incorporated herein by reference in their entirety as if fully set forth herein.


The current offerings of pre-wetted intermittent catheters can be broken up into three broad categories. In the first type, the catheter is packaged in a dry environment, but contains a lubricious coating that requires a wetting fluid in order to become hydrated. The wetting fluid is obtained from an external source by the user (e.g., sink, bottled water, etc.) and the catheter is positioned within the wetting fluid for a period of time to become hydrated. Use of this first type of intermittent catheter may prove difficult in the event that drainage must be performed by the user when no clean water or wetting fluid is available. Moreover, sterility of the catheter may be compromised due to the handling of the catheter by the user as wetting fluid is applied and thereafter during insertion.


A second type of pre-wetted intermittent catheter is also packaged in a dry environment and contains a lubricious coating. In this second type, the wetting fluid is positioned in a pouch or container within the catheter package itself such that to hydrate the catheter, the pouch or container must be opened when the user is ready for insertion. A third type of pre-wetted intermittent catheter is packaged in a wet environment (i.e., the catheter is exposed to a wetting fluid within the catheter package).


Intermittent catheterization is generally performed a minimum of three times a day by the patient or a care giver in order to drain the bladder. The genital area near the urethral opening is wiped with an antiseptic agent, such as iodine. A lubricant may then be used to facilitate the entry of the catheter into the urethra. A topical local anesthetic may also be applied to numb the urethral opening during the procedure. The catheter packaging is opened, and the catheter is removed. One end of the catheter is placed in a container, and the other end is inserted into and guided up the urethra and into the bladder until urine flow begins.


Some patients requiring intermittent catheterization may have limited dexterity resulting from, for example, traumatic brain or spinal cord injury, or a disease state (e.g., spina bifida, multiple schlerosis). Such patients may have difficulty opening the packaging of an intermittent catheter, and may further have difficulty during insertion. Fumbling with the catheter and/or its packaging is potentially harmful to the patient, because the sterile surfaces of the catheter may become non-sterile. Inserting a non-sterile urinary catheter increases the likelihood of contracting a urinary tract infection.


Packaging is a separate issue associated with intermittent urinary catheterization. It could be desirable to provide an intermittent urinary catheter in a discrete, compact packaged unit to improve the ease of use, convenience, and privacy of the intermittent catheterization process for the user.


Thus, there is a need for an intermittent catheter that addresses at least one of the needs of the patient or user, e.g., is easy to use, is quick, clean, compact, capable of use with or without a bag, and is capable of maintaining sterility during insertion procedures.


BRIEF SUMMARY OF THE INVENTION

Accordingly, a packaged urinary catheter is described herein, comprising a conduit having a proximal end and a distal end, wherein the distal end comprises at least one aperture for receiving urine from the bladder; a sleeve having a length, a width, and a size configured to receive the conduit, wherein the sleeve surrounds substantially the entire length of the conduit; and wherein the conduit and the sleeve are arranged in a helical coil.


In one embodiment, the shape of the helical coil is maintained by portions of the sleeve being releasably fixed together along at least a portion of the length of the sleeve.


In another embodiment, a first cap seals a proximal end of the sleeve, and a second cap seals a distal end of the sleeve.


In another embodiment, at least one of the first and second caps comprises a gripping feature configured to be grasped by a patient or user of the packaged urinary catheter.


In another embodiment, the gripping feature is sized and shaped to receive a finger therethrough.


In another embodiment, portions of the sleeve are releasably fixed together by a perforated section along a length of the sleeve.


In another embodiment, the packaged urinary catheter is released from the helical coil configuration by grasping the first and second caps, and urging the caps in substantially different directions.


In one embodiment, a lubricating material is contained within the sleeve.


In another embodiment, the lubricating material is chosen from water, a hydrogel, and a vapor.


In another embodiment, at least a portion of the outer surface of the conduit is hydrophilic.


In another embodiment, there is disclosed a synthetic polyisoprene conduit having a proximal end and a distal end, wherein the distal end comprises at least one aperture for receiving urine from the bladder; a sleeve having a length, and a width, and a size configured to receive the conduit, wherein the sleeve surrounds substantially the entire length of the conduit; and wherein the conduit and the sleeve are arranged in a helical coil.


These and other embodiments, methods, features and advantages will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates one embodiment of an intermittent catheter according to the present disclosure.



FIG. 2 illustrates one embodiment of an intermittent catheter in accordance with the present disclosure, with the end caps removed.



FIG. 3 illustrates a cutaway view of one embodiment of an intermittent catheter in accordance with the present disclosure.



FIG. 4 illustrates a side view of one embodiment of an intermittent catheter in accordance with the present disclosure.



FIG. 5 illustrates one embodiment of an intermittent catheter in accordance with the present disclosure.



FIG. 6 illustrates an intermittent catheter in a partially deployed configuration, in accordance with one aspect of the present disclosure.



FIG. 7A illustrates the proximal end of an intermittent catheter in a urine disposal bag, in accordance with one aspect of the present disclosure.



FIG. 7B illustrates a sealing washer at the distal end of a catheter sleeve, in accordance with one aspect of the present disclosure.





DESCRIPTION OF THE INVENTION

The following description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.


As used herein, the reference terms “proximal” and “distal” (proximal being closer than distal) refer to the proximity with respect to a health care professional or other person other than a patient that is assisting the patient in using the catheter apparatus. In the case that a user is implementing the catheter apparatus without the aid of another, “proximal” and “distal” refer to the proximity with respect to a point external to the user's body. Thus, for example, a region or section of the catheter apparatus that is close to a health care professional or the user's hand when the catheter apparatus is being utilized is referred to as “proximal,” while a region or section of the catheter apparatus distanced from a health care professional or the user's hand when the catheter apparatus being used is referred to as “distal.”


The packaged catheter, as described herein, is discussed in the context of a urinary catheter for insertion into a user/patient bladder for drainage of urine therefrom. However, it should be appreciated that the packaged catheter described could also be used for other applications not specifically mentioned herein, and therefore should not be limited to a urinary catheter application.


Generally, the packaged catheter includes a conduit, such as a catheter or tube, positioned within a sleeve. The conduit may have a round cross-sectional shape, an oval cross-sectional shape, or any other cross-sectional shape that may facilitate insertion into a user's body, and in particular into a user's bladder through the urethra. The conduit, in accordance with various embodiments, contains a lubricious and/or antimicrobial coating on at least an outer surface thereof. The lubricious coating can include a hydrogel or any coating that renders the surface of the conduit hydrophilic. Suitable non-limiting examples of such coatings that may be used on the catheters disclosed herein may be found in U.S. Pat. Nos. 6,329,488; 6,716,895; 6,949,598; 7,179,849; and 8,784,928, filed Jan. 11, 2012, which is a National Phase application of International Application No. PCT/US2011/62086, titled “Deposition of a Silver Layer on a Non-Conducting Substrate,” and published as WO 2012/071536. Each of the above-listed patents, publications, and applications is incorporated by reference into this application as if fully set forth herein.


Referring now to FIGS. 1-2, one embodiment of a packaged urinary catheter 10 is shown, including a conduit 16 disposed within a flexible sleeve 20. Conduit 16 has a proximal end 14, a distal end 12, an eyelet 18 to receive urine, and a funnel 26 to dispense urine. The connection between the conduit 16 and the funnel 26 can be accomplished by any method known to bond such materials together, for example by molding and or chemically bonding (with, e.g., cyclohexanone). Sleeve 20 has a length, a width, and a size configured to receive the conduit 16, and the sleeve surrounds substantially the entire length of the conduit 16.


According to certain embodiments, the sleeve 20 is made of a gas impermeable material, such as a polymer, for example polypropylene or polyethylene. According to one embodiment, sleeve 20 is made of a non-rigid material, such as, for example, a foil material or the like, or films, such as polymeric films, for example polypropylene and polyethylene films. The sleeve may be constructed from two blanks of material that are joined at the edges to form the sleeve. The edges of the blanks may be joined by typical methods known to those of ordinary skill in the art, including heat, sonic, chemical, or physical bonding.


According to one embodiment, the sleeve 20 is configured to collapse upon itself to facilitate introduction of the conduit by a user and to prevent direct contact by the user with the conduit. The sleeve 20 may include an introduction member (not shown) at the proximal end thereof to facilitate introduction of the conduit to facilitate disposal of the drained urine. A suitable non-limiting example of an introducer is disclosed in U.S. Pat. No. 4,692,154 (the disclosure of which is incorporated herein by reference in its entirety).


According to various embodiments, the sleeve contains within it a wetting fluid. The purpose of the wetting fluid is to maintain hydration of a lubricious coating on the conduit 16 such that upon insertion of the conduit into a user, at least an outer portion thereof is extremely slippery, facilitating insertion.


The packaged catheter 10 includes first cap 24 for covering the proximal end 14 of conduit 16, and a second cap 22 for covering distal end 12 of conduit 16. The distal cap 22 has a lumen 36 (FIG. 2) configured to receive the distal tip of conduit 16. According to one embodiment, the lumen 36 receives both the distal tip of the conduit 16 and the distal end of the sleeve 20. According to another embodiment, the distal end of the sleeve is releasably joined to the proximal end of cap 22. According to yet another embodiment, the inside diameter of sleeve 20 is joined to the outside diameter of lumen 36.


Similarly, proximal cap 24 has a lumen 38 configured to receive the funnel 26 of conduit 16. According to one embodiment, the lumen 38 receives both the funnel and the proximal end of the sleeve 20. According to another embodiment, the proximal end of the sleeve 20 is releasably joined to the distal end of cap 24. According to yet another embodiment, the inside diameter of lumen 38 is releasably joined to the outside diameter of 20.


Patients who self-catheterize may have limited dexterity. Accordingly, it could be advantageous to provide caps 22 and 24 with grasping features to facilitate removal by those of limited dexterity. According to certain embodiments, caps 22 and 24 may have apertures 29 and 30, respectively, sized and shaped to receive at least one finger. Other grasping features known to those of ordinary skill in the art are also within the scope of the present disclosure.


According to certain embodiments, the sleeve 20 may have a tubular outer surface with a plurality of pre-formed pleats or folds (not shown) along a middle portion thereof between a proximal end section 32 and a distal end section 34 of packaged catheter 10. The pleats or folds in the outer surface of the sleeve 20 permit the sleeve to compress or collapse upon itself in accordion-like fashion. According to another embodiment, the sleeve 20 does not contain pre-formed pleats or folds, but instead is comprised of a thin, substantially flat, collapsible material.


The packaged catheter according to the present disclosure is designed to provide a compact configuration for discreet transport and usage. This may be accomplished by providing the catheter in a folded or coiled configuration. The present disclosure contemplates helical coils, as well as flat coils, or coils having any other configuration suitable for packaging. Such a configuration may allow a user to stow a sufficient number of catheters in a backpack, purse, or pocket while preserving the user's privacy and dignity.



FIGS. 1-2 show a packaged urinary catheter in a coiled configuration. According to one embodiment, the “coils” of the packaged catheter are held together at joined edges 28 of the sleeve 20. The joined edges 28 can be held together by a perforation in the sleeve 20, or by any conventional bonding method known to those of ordinary skill in the art. The packaged catheter 10 is shown in cross-section in FIG. 3. A side view of the packaged catheter 10 is shown in FIG. 4.


Cap 24 is configured for removal from the distal end 14 of the packaged catheter, and urine is permitted to drain from funnel 26. In one embodiment, the drainage funnel 26 of the conduit 16 is configured such that it can be inserted into, or otherwise connected to, a bag 40 (FIG. 7) and sealed (or at least partially sealed) thereto such that fluid communication between the funnel 26 and the bag is established and a closed system is provided to prevent exposure to contaminants to the user or assistant (nurse, family member, etc.). Drainage of a user's bladder can then take place directly into the bag 40, which can subsequently be detached from the funnel 26 and either emptied and sanitized, or disposed of, in the case that the bag is made of a disposable material.


In one embodiment the bag includes an extension member (not shown) extending from an opening therein that both connects to the funnel 26 and is shaped to receive the cap 24. According to another embodiment, the bag has a closure member 42 at the distal end thereof, allowing the bag to be closed once the catheterization process is completed. According to another embodiment, the bag 40 is sized and shaped to hold a volume of urine and the used catheter and sleeve. According to yet another embodiment, the bag 40 is packaged together with the catheter. For example, the bag can be provided in a folded configuration in the center 3 of the coiled catheter (FIG. 1), thus minimizing the total space occupied by the packaged catheter 10.


According to one embodiment, and as exemplified in FIG. 7B, a sliding seal member 42, such as a compressible washer, is incorporated into the distal end sleeve 20, through which the conduit 16 is slidably positioned, to permit sliding of the conduit 16 with respect to the sleeve 20. The seal formed between sleeve 20 and sliding seal member 42, and between sliding seal member 42 and conduit 16, may serve a number of purposes. For example, the seals may help to minimize exposure of the outer surface of the conduit 16 to the environment, thus minimizing an infection risk. In addition, the seals may prevent loss or leakage of the wetting fluid from the volume formed between the inside surface of sleeve 20 and the outside surface of conduit 16. The inside diameter of the end of sleeve 20 may be bonded to the outside diameter of the seal member 42.


The catheter may have a round or substantially round cross-sectional shape, an oval cross-sectional shape, or any other cross-sectional shape that may facilitate insertion into the body of a user/patient, and in particular, into the bladder of the user/patient through the urethra. According to various embodiments, the shape of the catheter can also be variable along its length.


Different lengths, sizes (e.g., diameter, width, etc.), and configurations are possible for the conduit 16, depending on the user's anatomy. For female users, the insertable length may range from 40 to 100 mm, for example 50 to 80 mm, such as 55 to 75 mm. For male users, the insertable length can range from 100 to 300 mm, such as 190 to 240 mm, for example 230 mm. For example, in one embodiment for an adult male human, the length of the conduit 16 may be in the range of about 8 to about 18 cm and have an elliptical cross-sectional shape similar to the shape of the male urethra.


The proximal end of the conduit 16 includes a tip having a rounded atraumatic shape (e.g., bullet shape, etc.) and at least one opening 18 or “eyes” in the sides of the tip that connect with a central conduit lumen such that placement of the conduit tip into a urine pool in the bladder results in drainage of urine therefrom. The tip design can vary according to the needs of a user, for example, the catheters disclosed herein can be provided with a coude tip.


As mentioned above, at least a portion of the outer surface of the conduit 16 is coated with a lubricious coating, which when contacted by a wetting fluid, becomes hydrated. The hydration of the lubricious coating results in a surface with a low coefficient of friction such that the conduit 16 is easily slidable into the body of a user. The lubricious coating is made from a material such as those described in U.S. Pat. No. 6,329,488 or 4,642,267, the disclosures of which are incorporated herein by reference in their entirety.


One of the advantages associated with the packaged catheter of the present disclosure is ease of use. From the coiled configuration, a user can grab each of caps 22 and 24, optionally through apertures 29 and 30, and urge the caps in substantially opposing directions shown by arrows A and B (FIG. 5). The resulting force will uncoil the packaged catheter by allowing the edges 28 of the sleeve 20 to separate (FIG. 6). Once the coils are sufficiently separated, the user can begin the catheterization process. Cap 22 can be secured to the distal end of the conduit 16 or sleeve 20 by friction fit, threaded engagement (i.e., either the cap or the distal end section contains threads, protrusions, etc. while the other contains grooves, detents, recesses, etc. to receive the threads, protrusions, etc.), or other like securing methods known to one skilled in the art. Once cap 22 is removed, the distal end of conduit 16 is inserted into the urethral meatus. According to one embodiment, the conduit is inserted in a way that avoids the user directly touching the surface of the conduit (in order to minimize dragging harmful bacteria into the user's urinary tract). This can be done by manipulating the conduit 16 only through sleeve 20.


Referring now to the device as illustrated in FIGS. 1-7, the packaged catheter 10 as shown in FIG. 1 is coiled. The conduit 16, being contained completely within the sleeve 20 and surrounded by wetting fluid, is in a sterile condition and remains that way due to caps 22 and 24. Cap 24 is removed, and the bag 40, which may be separately packaged or packaged along with the catheter apparatus 10, is connected to the funnel 26 extending from the distal end of the catheter apparatus 10 as shown in FIG. 7A (in alternate embodiments not employing a bag, this step is not performed). According to another embodiment, the packaged catheter has a bag 40 that surrounds cap 24, such that cap 24 is disconnected by manipulating the cap through the bag.


Once the bag 40 has been connected to the catheter apparatus 10 and the user is ready for insertion, the cap 22 is removed from the distal end 12 of the conduit 16, and the conduit tip is placed into the user. The user or assistant then holds the catheter apparatus 10 at a distal end (e.g., the user grasps the funnel 26 with one hand, and the sleeve 20 or washer 42 with the other hand) and pushes in a distal direction to extend the conduit 16 into the user and eventually into the user's bladder, while simultaneously collapsing the sleeve 20 onto itself. This action minimizes or eliminates exposure of the conduit 16 to conditions or contaminants outside of the container. Drainage of urine from the user's bladder then takes place and following evacuation, the proximal end of the catheter apparatus 10 is pulled in a proximal direction, while the distal end of the sleeve 20 (or the sealing member 42) is held in place. This action results in the conduit 16 returning fully inside the sleeve 20 so that the user or assistant is not exposed to potential contaminants. In the embodiment in which a bag 40 is attached to the proximal end 14 (or the funnel 26) of the catheter apparatus 10, the bag 40 is subsequently removed and disposed of (or emptied and sanitized). In an embodiment in which a bag 40 is not attached to the proximal end 14 or funnel 26 of the catheter apparatus 10, the funnel is directed into a disposal collection member or waste disposal apparatus, such as a toilet, during evacuation of the bladder.


The conduit 16 may be constructed from a suitable polymeric material, such as polyvinyl chloride (PVC), silicone, latex or other synthetic rubber. The components of the catheter disclosed herein can also be made from various well-known materials. For example, the portions of the assembly other than the conduit 16 can be made of polyvinyl propylene, polyvinyl chloride, polyethylene, polypropylene, and other types of suitable polymeric materials. The components can be molded or extruded according to well-known manufacturing techniques.


Materials commonly used to make the conduit 16 include, but are not limited to natural rubber latexes (available, for example, from Guthrie, Inc., Tucson, Ariz.; Firestone, Inc., Akron, Ohio; and Centrotrade USA, Virginia Beach, Va.), silicones (available, for example, from GE Silicones, Waterford, N.Y., Wacker Silicones, Adrian, Mich.; and Dow Corning, Inc., Midland, Mich.), polyvinyl chlorides (available, for example, from Kaneka Corp., Inc., New York, N.Y.), polyurethanes (available, for example, from Bayer, Inc., Toronto, Ontario, Rohm & Haas Company, Philadelphia, Pa.; and Ortec, Inc., Greenville, S.C.), plastisols (available, for example, from G S Industries, Bassett, Va.), polyvinyl acetate, (available, for example from Acetex Corp., Vancouver, British Columbia) polyacrylates (available, for example, from Rohm and Haas, Philadelphia, Pa.) and methacrylate copolymers (available, for example, from Heveatex, Inc., Fall River, Mass.). Synthetic and natural rubber latexes, polyurethanes, and silicones are preferred materials. Any combination of the foregoing materials may also be used in making catheters such as are used to produce latex Foley catheters.


The urinary catheter of the present disclosure can be manufactured by a variety of well-known methods. The tubing can be extruded and the funnel injection molded and then cut to the desired length. The tip of the tube can then be closed and rounded by thermoforming (for example, for PVC tubes) or molded (for example, for silicone tubes). Eye holes can then be punched or otherwise formed near the tip of the distal end of the tube to provide an outlet for urine drainage thru the tube when it is inserted into a bladder.


Alternatively, the entire catheter can be fabricated by dip molding. In this procedure, an elongated rod or “form” is dipped into a liquid coating material such as synthetic or natural rubber latex, for example, to form a layer of material on the form. The deposition of material can be increased by first dipping the form into a coagulant solution to coat the form with a film of chemical that causes the latex to coagulate onto the form. Calcium nitrate is commonly used as the coagulant, and other additives may be used to enhance the removal of the tube from the form once the catheter is formed and dried. The form has the shape and dimensions of the lumen of the catheter. The catheter may be formed from a single dip coating of the form or by multiple coating layers. When a suitable material thickness is achieved on a form, the forms are dried to produce the catheter. If multiple coatings are used to form the catheter, each coating may be dried before the next is applied. Once dried, the catheter may be stripped from the form. The catheters may then be washed and dried, and eyelets may then be formed thereon. Further manufacturing steps may be found in U.S. Pat. No. 7,628,784, the disclosure of which is incorporated by reference herein.


This invention has been described and specific examples of the invention have been portrayed. While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Finally, all publications and patent applications cited in this specification are herein incorporated by reference in their entirety as if each individual publication or patent application were specifically and individually put forth herein.

Claims
  • 1. A method of making a catheter assembly, comprising: forming a urinary catheter, including forming a tip on a distal end of the urinary catheter and forming a proximal end of the urinary catheter;surrounding the urinary catheter with a sleeve;wrapping the urinary catheter and the sleeve in a helical coil configuration; andreleasably fixing adjacent portions of the sleeve together to maintain the helical coil configuration.
  • 2. The method according to claim 1, further comprising positioning a first cap over the proximal end of the urinary catheter to seal a proximal opening of the sleeve, and positioning a second cap over the distal end of the urinary catheter to seal a distal opening of the sleeve.
  • 3. The method according to claim 2, wherein at least one of the first and second caps comprises a gripping feature.
  • 4. The method according to claim 3, wherein the gripping feature is sized and shaped to receive a finger therethrough.
  • 5. The method according to claim 1, wherein the releasably fixing adjacent portions includes providing a perforated section between the adjacent portions.
  • 6. The method according to claim 1, wherein forming the proximal end of the urinary catheter includes forming a funnel.
  • 7. The method according to claim 1, further comprising providing a lubricating material within the sleeve, the lubricating material designed to lubricate the distal end of the urinary catheter prior to use.
  • 8. The method according to claim 7, wherein the lubricating material is selected from the group consisting of water, a hydrogel, and a vapor.
  • 9. The method according to claim 1, wherein an outer surface of the urinary catheter is hydrophilic.
  • 10. The method according to claim 1, wherein the sleeve is constructed from two blanks of material that are joined at edges of the two blanks of material thereof.
  • 11. The method according to claim 1, wherein the sleeve is constructed from a foil material or a film.
  • 12. The method according to claim 1, wherein forming the urinary catheter includes extruding a tubing, and wherein forming the distal end of the urinary catheter comprises closing the distal end, rounding the tip, and forming eye holes adjacent the tip to provide fluid communication with a lumen of the urinary catheter.
  • 13. The method according to claim 1, wherein forming the urinary catheter includes dipping an elongated rod into a liquid coating material to form one or more layers of material on the elongated rod.
  • 14. The method according to claim 13, wherein forming the urinary catheter further comprises dipping the elongated rod into a coagulant solution prior to dipping into the liquid coating material.
  • 15. The method according to claim 13, wherein the liquid coating material comprises synthetic polyisoprene.
PRIORITY

This application is a continuation of U.S. patent application Ser. No. 14/681,023, filed Apr. 7, 2015, now U.S. Pat. No. 9,694,113, which is a continuation of U.S. patent application Ser. No. 13/802,095, filed Mar. 13, 2013, now U.S. Pat. No. 8,998,882, each of which is incorporated by reference in its entirety into this application.

US Referenced Citations (474)
Number Name Date Kind
1888349 Jacoby Nov 1932 A
2912981 Keough Nov 1959 A
2919697 Kim Jan 1960 A
3173566 Talbert Mar 1965 A
3246075 Dansard Apr 1966 A
3344791 Foderick Oct 1967 A
3345988 Vitello Oct 1967 A
3556294 Walck et al. Jan 1971 A
3556874 McClain Jan 1971 A
3566874 Shepherd et al. Mar 1971 A
3648704 Jackson Mar 1972 A
3695921 Shepherd et al. Oct 1972 A
3699964 Ericson Oct 1972 A
3726281 Norton et al. Apr 1973 A
3794042 De Klotz et al. Feb 1974 A
3802987 Noll Apr 1974 A
3835992 Adams, IV Sep 1974 A
3854483 Powers Dec 1974 A
3861395 Taniguchi Jan 1975 A
3894540 Bonner, Jr. Jul 1975 A
3898993 Taniguchi Aug 1975 A
3934721 Juster et al. Jan 1976 A
3967728 Gordon et al. Jul 1976 A
4026296 Stoy et al. May 1977 A
4051849 Poncy et al. Oct 1977 A
4055682 Merrill Oct 1977 A
4062363 Bonner, Jr. Dec 1977 A
4069359 DeMarse et al. Jan 1978 A
4091922 Egler May 1978 A
4140127 Cianci et al. Feb 1979 A
4198983 Becker et al. Apr 1980 A
4230115 Walz, Jr. et al. Oct 1980 A
4245639 La Rosa Jan 1981 A
4246909 Wu et al. Jan 1981 A
4269310 Uson et al. May 1981 A
4306557 North Dec 1981 A
4350161 Davis, Jr. Sep 1982 A
4351333 Lazarus et al. Sep 1982 A
4366901 Short Jan 1983 A
4392848 Lucas et al. Jul 1983 A
4411648 Davis et al. Oct 1983 A
4515593 Norton May 1985 A
4517971 Sorbonne May 1985 A
4560382 Isono et al. Dec 1985 A
4571241 Christopher Feb 1986 A
4585666 Lambert Apr 1986 A
4597765 Klatt Jul 1986 A
4607746 Stinnette Aug 1986 A
4610670 Spencer Sep 1986 A
4619642 Spencer Oct 1986 A
4681572 Tokarz et al. Jul 1987 A
4692154 Singery et al. Sep 1987 A
4696672 Mochizuki et al. Sep 1987 A
4704102 Guthery Nov 1987 A
4723946 Kay Feb 1988 A
4738667 Galloway Apr 1988 A
4754877 Johansson et al. Jul 1988 A
4759753 Schneider et al. Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4773901 Norton Sep 1988 A
4784651 Hickey et al. Nov 1988 A
4811847 Reif et al. Mar 1989 A
4838876 Wong et al. Jun 1989 A
4886508 Washington Dec 1989 A
4888005 Dingeman et al. Dec 1989 A
4893623 Rosenbluth Jan 1990 A
4932938 Goldberg et al. Jun 1990 A
4957487 Gerow Sep 1990 A
4997426 Dingeman et al. Mar 1991 A
5007897 Kalb et al. Apr 1991 A
5045078 Asta Sep 1991 A
5077352 Elton Dec 1991 A
5087252 Denard Feb 1992 A
5098379 Conway et al. Mar 1992 A
5100396 Zamierowski Mar 1992 A
5137671 Conway et al. Aug 1992 A
5147341 Starke et al. Sep 1992 A
5174290 Fiddian-Green Dec 1992 A
5179174 Elton Jan 1993 A
5180591 Magruder et al. Jan 1993 A
5186172 Fiddian-Green Feb 1993 A
5188596 Condon et al. Feb 1993 A
5201724 Hukins et al. Apr 1993 A
5209726 Goosen May 1993 A
5209728 Kraus et al. May 1993 A
5224953 Morgentaler Jul 1993 A
5226530 Golden Jul 1993 A
5234411 Vaillancourt Aug 1993 A
5236422 Eplett, Jr. Aug 1993 A
5242398 Knoll et al. Sep 1993 A
5242428 Palestrant Sep 1993 A
5261896 Conway et al. Nov 1993 A
5269755 Bodicky Dec 1993 A
5269770 Conway et al. Dec 1993 A
5282795 Finney Feb 1994 A
5352182 Kalb et al. Oct 1994 A
5360402 Conway et al. Nov 1994 A
5370899 Conway et al. Dec 1994 A
5415165 Fiddian-Green May 1995 A
5417666 Coulter May 1995 A
5433713 Trotta Jul 1995 A
5445626 Gigante et al. Aug 1995 A
5447231 Kastenhofer Sep 1995 A
5454798 Kubalak et al. Oct 1995 A
5456251 Fiddian-Green Oct 1995 A
5466229 Elson et al. Nov 1995 A
5476434 Kalb et al. Dec 1995 A
5482740 Conway et al. Jan 1996 A
5501669 Conway et al. Mar 1996 A
5509889 Kalb et al. Apr 1996 A
5514112 Chu et al. May 1996 A
5520636 Korth et al. May 1996 A
5531715 Engelson et al. Jul 1996 A
5531717 Roberto et al. Jul 1996 A
5536258 Folden Jul 1996 A
5558900 Fan et al. Sep 1996 A
5569219 Hakki et al. Oct 1996 A
5582599 Daneshvar Dec 1996 A
5591292 Blomqvist Jan 1997 A
5599321 Conway et al. Feb 1997 A
5601537 Frassica Feb 1997 A
5607417 Batich et al. Mar 1997 A
5616126 Malekmehr et al. Apr 1997 A
5624395 Mikhail et al. Apr 1997 A
5653700 Byrne et al. Aug 1997 A
5670111 Conway et al. Sep 1997 A
5688516 Raad et al. Nov 1997 A
5695456 Cartmell Dec 1997 A
5704353 Kalb et al. Jan 1998 A
5707357 Mikhail et al. Jan 1998 A
5711841 Jaker Jan 1998 A
5749826 Faulkner May 1998 A
5779670 Bidwell et al. Jul 1998 A
5782808 Folden Jul 1998 A
5785694 Cohen et al. Jul 1998 A
5788687 Batich et al. Aug 1998 A
5800339 Salama Sep 1998 A
5817067 Tsukada et al. Oct 1998 A
5820583 Demopulos et al. Oct 1998 A
5840151 Munsch Nov 1998 A
5848691 Morris et al. Dec 1998 A
5853518 Utas et al. Dec 1998 A
5871475 Frassica Feb 1999 A
5895374 Rodsten et al. Apr 1999 A
5897535 Feliziani et al. Apr 1999 A
5941856 Kovacs et al. Aug 1999 A
5958167 Van Driel Sep 1999 A
5971954 Conway et al. Oct 1999 A
5980483 Dimitri et al. Nov 1999 A
5989230 Frassica Nov 1999 A
6004305 Hursman et al. Dec 1999 A
6007521 Bidwell et al. Dec 1999 A
6024751 Lovato et al. Feb 2000 A
6050934 Mikhail et al. Apr 2000 A
6053905 Daignault, Jr. et al. Apr 2000 A
6056715 Demopulos et al. May 2000 A
6059107 Nosted et al. May 2000 A
6063063 Harboe et al. May 2000 A
6090075 House Jul 2000 A
6156049 Lovato et al. Dec 2000 A
6162201 Cohen et al. Dec 2000 A
6183461 Matsuura et al. Feb 2001 B1
6186990 Chen et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6210394 Demopulos et al. Apr 2001 B1
6217569 Fiore Apr 2001 B1
6221056 Silverman Apr 2001 B1
6238383 Karram et al. May 2001 B1
6254570 Rutner et al. Jul 2001 B1
6254582 O'Donnell et al. Jul 2001 B1
6254585 Demopulos et al. Jul 2001 B1
6261279 Demopulos et al. Jul 2001 B1
6293923 Yachia et al. Sep 2001 B1
6299598 Bander Oct 2001 B1
6306422 Batich et al. Oct 2001 B1
6329488 Terry et al. Dec 2001 B1
6340359 Silverman Jan 2002 B1
6355004 Pedersen et al. Mar 2002 B1
6358229 Tihon Mar 2002 B1
6368315 Gillis et al. Apr 2002 B1
6368317 Chang Apr 2002 B2
6379334 Frassica Apr 2002 B1
6383434 Conway et al. May 2002 B2
6391010 Wilcox May 2002 B1
6391014 Silverman May 2002 B1
6398718 Yachia et al. Jun 2002 B1
6402726 Genese Jun 2002 B1
6409717 Israelsson et al. Jun 2002 B1
6458867 Wang et al. Oct 2002 B1
6468245 Alexandersen et al. Oct 2002 B2
6485476 von Dyck et al. Nov 2002 B1
6544240 Borodulin et al. Apr 2003 B1
6578709 Kavanagh et al. Jun 2003 B1
6582401 Windheuser et al. Jun 2003 B1
6602244 Kavanagh et al. Aug 2003 B2
6613342 Aoki Sep 2003 B2
6626888 Conway et al. Sep 2003 B1
6629969 Chan et al. Oct 2003 B2
6634498 Kayerod et al. Oct 2003 B2
6638269 Wilcox Oct 2003 B2
6648906 Lasheras et al. Nov 2003 B2
6659937 Polsky et al. Dec 2003 B2
6682555 Cioanta et al. Jan 2004 B2
6695831 Tsukada et al. Feb 2004 B1
6711436 Duhaylongsod Mar 2004 B1
6716895 Terry Apr 2004 B1
6719709 Whalen et al. Apr 2004 B2
6730113 Eckhardt et al. May 2004 B2
6736805 Israelsson et al. May 2004 B2
6746421 Yachia et al. Jun 2004 B2
6783520 Candray et al. Aug 2004 B1
D496266 Nestenborg et al. Sep 2004 S
6824532 Gillis et al. Nov 2004 B2
6835183 Lennox et al. Dec 2004 B2
6840379 Franks-Farah et al. Jan 2005 B2
6848574 Israelsson et al. Feb 2005 B1
6849070 Hansen et al. Feb 2005 B1
6852105 Bolmsjo et al. Feb 2005 B2
D503335 Risberg et al. Mar 2005 S
6869416 Windheuser et al. Mar 2005 B2
6887230 Kubalak et al. May 2005 B2
6889740 Globensky et al. May 2005 B1
6918924 Lasheras et al. Jul 2005 B2
6926708 Franks-Farah et al. Aug 2005 B1
6939339 Axexandersen et al. Sep 2005 B1
6941171 Mann et al. Sep 2005 B2
6942634 Odland Sep 2005 B2
6945957 Freyman Sep 2005 B2
6949598 Terry Sep 2005 B2
7001370 Kubalak et al. Feb 2006 B2
7048717 Frassica May 2006 B1
7059330 Makower et al. Jun 2006 B1
7066912 Nestenborg et al. Jun 2006 B2
7087041 von Dyck et al. Aug 2006 B2
7087048 Israelsson et al. Aug 2006 B2
7094220 Tanghoj et al. Aug 2006 B2
7160277 Elson et al. Jan 2007 B2
7166092 Elson et al. Jan 2007 B2
7195608 Burnett Mar 2007 B2
7244242 Freyman Jul 2007 B2
7250043 Chan et al. Jul 2007 B2
7255687 Huang et al. Aug 2007 B2
7270647 Karpowicz et al. Sep 2007 B2
7294117 Provost-tine et al. Nov 2007 B2
7311690 Burnett Dec 2007 B2
7311698 Tanghoj et al. Dec 2007 B2
7331948 Skarda Feb 2008 B2
7334679 Givens, Jr. Feb 2008 B2
7374040 Lee et al. May 2008 B2
7380658 Murray et al. Jun 2008 B2
7445812 Schmidt et al. Nov 2008 B2
7458964 Mosler et al. Dec 2008 B2
7476223 McBride Jan 2009 B2
7507229 Hewitt et al. Mar 2009 B2
7517343 Tanghoj et al. Apr 2009 B2
7537589 Tsukada et al. May 2009 B2
7571804 Kjellmann Bruun et al. Aug 2009 B2
7601158 House Oct 2009 B2
7615045 Israelsson et al. Nov 2009 B2
7628784 Diaz et al. Dec 2009 B2
7632256 Mosler et al. Dec 2009 B2
7662146 House Feb 2010 B2
7682353 Tanghoj et al. Mar 2010 B2
7770726 Murray et al. Aug 2010 B2
7789873 Kubalak et al. Sep 2010 B2
7823722 Bezou et al. Nov 2010 B2
7846133 Windheuser et al. Dec 2010 B2
7938838 House May 2011 B2
7947021 Bourne et al. May 2011 B2
7985217 Mosler et al. Jul 2011 B2
8011505 Murray et al. Sep 2011 B2
8051981 Murray et al. Nov 2011 B2
8066693 Tanghoj et al. Nov 2011 B2
8177774 House May 2012 B2
8181778 Van Groningen et al. May 2012 B1
8205745 Murray et al. Jun 2012 B2
8328792 Nishtala et al. Dec 2012 B2
8454569 Kull-Osterlin et al. Jun 2013 B2
8459455 Frojd Jun 2013 B2
8475434 Frojd Jul 2013 B2
8998882 Knapp et al. Apr 2015 B2
9033149 Terry May 2015 B2
9114227 Blanchard Aug 2015 B2
9694113 Knapp et al. Jul 2017 B2
9731093 Terry Aug 2017 B2
9821139 Carleo Nov 2017 B2
10149961 Carleo Dec 2018 B2
20010001443 Kayerod et al. May 2001 A1
20010031952 Karram et al. Oct 2001 A1
20010047147 Slepian et al. Nov 2001 A1
20010054562 Pettersson et al. Dec 2001 A1
20020007175 Chang Jan 2002 A1
20020037943 Madsen Mar 2002 A1
20020045855 Frassica Apr 2002 A1
20020055730 Yachia et al. May 2002 A1
20020077611 von Dyck et al. Jun 2002 A1
20020082551 Yachia et al. Jun 2002 A1
20020087131 Wolff et al. Jul 2002 A1
20020094322 Lawson et al. Jul 2002 A1
20020095133 Gillis et al. Jul 2002 A1
20020099356 Unger et al. Jul 2002 A1
20020103467 Kubalak Aug 2002 A1
20020107467 Levin Aug 2002 A1
20020132013 Moulis Sep 2002 A1
20020133130 Wilcox Sep 2002 A1
20020156440 Israelsson et al. Oct 2002 A1
20020165427 Yachia et al. Nov 2002 A1
20030004496 Tanghoj Jan 2003 A1
20030018293 Tanghoj et al. Jan 2003 A1
20030018302 Kavanagh et al. Jan 2003 A1
20030018322 Tanghoj et al. Jan 2003 A1
20030028174 Chan et al. Feb 2003 A1
20030036802 Lennox et al. Feb 2003 A1
20030055403 Nestenborg et al. Mar 2003 A1
20030060807 Tanghoj et al. Mar 2003 A1
20030065292 Darouiche et al. Apr 2003 A1
20030130646 Kubalak et al. Jul 2003 A1
20030132307 Park Jul 2003 A1
20030135200 Byrne Jul 2003 A1
20030163079 Burnett Aug 2003 A1
20030195478 Russo Oct 2003 A1
20030225392 McMichael et al. Dec 2003 A1
20030233084 Slepian et al. Dec 2003 A1
20040030301 Hunter Feb 2004 A1
20040034329 Mankus et al. Feb 2004 A1
20040044307 Richardson et al. Mar 2004 A1
20040049152 Nayak Mar 2004 A1
20040049170 Snell Mar 2004 A1
20040055925 Franks-Farah et al. Mar 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040068251 Chan et al. Apr 2004 A1
20040074794 Conway et al. Apr 2004 A1
20040116551 Terry Jun 2004 A1
20040127848 Freyman Jul 2004 A1
20040133156 Diaz et al. Jul 2004 A1
20040147871 Burnett Jul 2004 A1
20040153049 Hewitt et al. Aug 2004 A1
20040153051 Israelsson et al. Aug 2004 A1
20040158231 Tanghoj et al. Aug 2004 A1
20040163980 Tanghoj et al. Aug 2004 A1
20040176747 Feneley Sep 2004 A1
20040243104 Seddon Dec 2004 A1
20040249343 Cioanta Dec 2004 A1
20040254562 Tanghoj et al. Dec 2004 A1
20040256264 Israelsson et al. Dec 2004 A1
20050003118 Takala Jan 2005 A1
20050015076 Giebmeyer et al. Jan 2005 A1
20050031872 Schmidt et al. Feb 2005 A1
20050033222 Haggstrom et al. Feb 2005 A1
20050043715 Nestenborg et al. Feb 2005 A1
20050049577 Snell et al. Mar 2005 A1
20050059990 Ayala et al. Mar 2005 A1
20050065499 Douk et al. Mar 2005 A1
20050070882 McBride Mar 2005 A1
20050080399 Bolmsjo et al. Apr 2005 A1
20050096582 Burnett May 2005 A1
20050101923 Elson et al. May 2005 A1
20050101924 Elson et al. May 2005 A1
20050107735 Lennox et al. May 2005 A1
20050109648 Kerzman et al. May 2005 A1
20050137522 Aoki Jun 2005 A1
20050137582 Kull-Osterlin et al. Jun 2005 A1
20050143690 High Jun 2005 A1
20050148950 Windheuser et al. Jul 2005 A1
20050197531 Cabiri et al. Sep 2005 A1
20050199521 Givens Sep 2005 A1
20050209580 Freyman Sep 2005 A1
20050214443 Madsen Sep 2005 A1
20050245901 Floyd Nov 2005 A1
20050251108 Frassica Nov 2005 A1
20050256447 Richardson et al. Nov 2005 A1
20050273034 Burnett Dec 2005 A1
20050283136 Skarda Dec 2005 A1
20060025753 Kubalak et al. Feb 2006 A1
20060027854 Kim et al. Feb 2006 A1
20060030864 Kennedy et al. Feb 2006 A1
20060036208 Burnett Feb 2006 A1
20060041246 Provost-tine et al. Feb 2006 A1
20060054557 Hori et al. Mar 2006 A1
20060058777 Nielsen Mar 2006 A1
20060064065 Russo Mar 2006 A1
20060079835 Frassica Apr 2006 A1
20060079854 Kay et al. Apr 2006 A1
20060100511 Eriksen May 2006 A1
20060122566 Huang et al. Jun 2006 A1
20060122568 Elson et al. Jun 2006 A1
20060163097 Murray et al. Jul 2006 A1
20060172096 Kyle et al. Aug 2006 A1
20060184112 Horn et al. Aug 2006 A1
20060184145 Ciok et al. Aug 2006 A1
20060196783 Bruun et al. Sep 2006 A1
20060200079 Magnusson Sep 2006 A1
20060263404 Nielsen et al. Nov 2006 A1
20060271019 Stoller et al. Nov 2006 A1
20060276894 Finley Dec 2006 A1
20060278546 State et al. Dec 2006 A1
20060293642 Israelsson et al. Dec 2006 A1
20070005041 Frassica et al. Jan 2007 A1
20070010798 Stoller et al. Jan 2007 A1
20070016169 Utas et al. Jan 2007 A1
20070049879 Gutierrez Mar 2007 A1
20070066963 Tanghoj Mar 2007 A1
20070106233 Huang et al. May 2007 A1
20070112327 Yun et al. May 2007 A1
20070149929 Utas et al. Jun 2007 A1
20070197957 Hunter et al. Aug 2007 A1
20070225635 Lynn Sep 2007 A1
20070225649 House Sep 2007 A1
20070225687 House Sep 2007 A1
20070244449 Najafi et al. Oct 2007 A1
20070289887 Murray et al. Dec 2007 A1
20080006554 Duffy et al. Jan 2008 A1
20080015518 Huang et al. Jan 2008 A1
20080021382 Freyman Jan 2008 A1
20080027414 Tanghoj et al. Jan 2008 A1
20080033471 Paz et al. Feb 2008 A1
20080050446 Ziegler et al. Feb 2008 A1
20080051762 Tsukada et al. Feb 2008 A1
20080051763 Frojd Feb 2008 A1
20080077099 House Mar 2008 A1
20080082051 Miller et al. Apr 2008 A1
20080085949 McGhee Apr 2008 A1
20080091145 House Apr 2008 A1
20080097362 Mosler et al. Apr 2008 A1
20080097394 Lampropoulos et al. Apr 2008 A1
20080097411 House Apr 2008 A1
20080140010 Kennedy et al. Jun 2008 A1
20080140052 Moller et al. Jun 2008 A1
20080171973 House Jul 2008 A1
20080171998 House Jul 2008 A1
20080172016 House Jul 2008 A1
20080172042 House Jul 2008 A1
20080179208 Murray et al. Jul 2008 A1
20080200907 Nestenborg Aug 2008 A1
20080243091 Humphreys et al. Oct 2008 A1
20080249467 Burnett et al. Oct 2008 A1
20080249482 Erez Oct 2008 A1
20080275463 High Nov 2008 A1
20090024111 Borodulin et al. Jan 2009 A1
20090048537 Lydon et al. Feb 2009 A1
20090054876 Borodulin et al. Feb 2009 A1
20090065605 Roche et al. Mar 2009 A1
20090071851 Maki et al. Mar 2009 A1
20090099532 Cuevas et al. Apr 2009 A1
20090131917 Kavanagh et al. May 2009 A1
20090137985 Tanghoej et al. May 2009 A1
20090137986 Golden et al. May 2009 A1
20090149837 Tanghoj et al. Jun 2009 A1
20090156882 Chi Sing et al. Jun 2009 A1
20090200187 Nestenborg et al. Aug 2009 A1
20090299334 Nishtala et al. Dec 2009 A1
20090318900 Tanghoj et al. Dec 2009 A1
20100198195 Nishtala et al. Aug 2010 A1
20100228233 Kahn Sep 2010 A1
20100263327 Murray et al. Oct 2010 A1
20100324540 Paulen et al. Dec 2010 A1
20110028943 Lawson et al. Feb 2011 A1
20110056852 Frojd Mar 2011 A1
20110114520 Matthison-Hansen May 2011 A1
20110127186 Enns et al. Jun 2011 A1
20110137296 Tanghoj Jun 2011 A1
20110184386 House Jul 2011 A1
20120168324 Carleo Jul 2012 A1
20120179102 Blanchard et al. Jul 2012 A1
20120308805 Sella Dec 2012 A1
20120316515 Terry Dec 2012 A1
20130006226 Hong et al. Jan 2013 A1
20130048516 Nishtala et al. Feb 2013 A1
20130153446 Utas et al. Jun 2013 A1
20130186778 Terry Jul 2013 A1
20140262859 Knapp et al. Sep 2014 A1
20150238726 Terry Aug 2015 A1
20150273116 Knapp et al. Oct 2015 A1
20170326334 Terry Nov 2017 A1
Foreign Referenced Citations (102)
Number Date Country
2770300 Feb 2011 CA
2769026 Apr 2015 CA
102939127 Feb 2013 CN
100 38 521 Feb 2002 DE
10213411 Oct 2003 DE
0217771 Apr 1987 EP
247559 Dec 1987 EP
0252918 Jan 1988 EP
0479935 Apr 1992 EP
0677299 Oct 1995 EP
0699086 Mar 1996 EP
0815037 Jan 1998 EP
0909249 Apr 1999 EP
0923398 Jun 1999 EP
0935478 Aug 1999 EP
0959930 Dec 1999 EP
0977610 Feb 2000 EP
1023882 Aug 2000 EP
1090656 Apr 2001 EP
1115450 Jul 2001 EP
1131022 Sep 2001 EP
1145729 Oct 2001 EP
1175355 Jan 2002 EP
1237615 Sep 2002 EP
1245205 Oct 2002 EP
1308146 May 2003 EP
1406690 Apr 2004 EP
1409060 Apr 2004 EP
1420846 May 2004 EP
1420847 May 2004 EP
1427467 Jun 2004 EP
1498151 Jan 2005 EP
1629860 Mar 2006 EP
1641510 Apr 2006 EP
1642610 Apr 2006 EP
1642611 Apr 2006 EP
2060296 May 2009 EP
2459264 Jun 2012 EP
2464411 Jun 2012 EP
2515988 Oct 2012 EP
2542291 Jan 2013 EP
3078393 Nov 2017 EP
2967968 Sep 2018 EP
2731345 Sep 1996 FR
2 794 638 Dec 2000 FR
2284764 Jun 1995 GB
2319507 May 1998 GB
S55-12265 Mar 1980 JP
2001-500414 Jan 2001 JP
2002-530148 Sep 2002 JP
2002 282275 Oct 2002 JP
2007-501656 Feb 2007 JP
2011-510110 Mar 2011 JP
2013-500125 Jan 2013 JP
2013-515572 May 2013 JP
2009105497 Aug 2010 RU
198401296 Apr 1984 WO
1986006284 Nov 1986 WO
1991005577 May 1991 WO
1994016747 Aug 1994 WO
1996038192 Dec 1996 WO
1997026937 Jul 1997 WO
1997041811 Nov 1997 WO
1998006642 Feb 1998 WO
1998011932 Mar 1998 WO
1998019729 May 1998 WO
9846176 Oct 1998 WO
1999030761 Jun 1999 WO
2000016843 Mar 2000 WO
2000047494 Aug 2000 WO
2001043807 Jun 2001 WO
2001052763 Jul 2001 WO
2001093935 Dec 2001 WO
2002036192 May 2002 WO
2003002177 Jan 2003 WO
2003002178 Jan 2003 WO
2003008028 Jan 2003 WO
2003008029 Jan 2003 WO
2003064279 Aug 2003 WO
2003092779 Nov 2003 WO
2004030722 Apr 2004 WO
2004045696 Jun 2004 WO
2004045696 Jun 2004 WO
2004050155 Jun 2004 WO
2004052440 Jun 2004 WO
2004056414 Jul 2004 WO
2004075944 Sep 2004 WO
2004089454 Oct 2004 WO
2005004964 Jan 2005 WO
2005014055 Feb 2005 WO
2005061035 Jul 2005 WO
2005092418 Oct 2005 WO
2007050685 May 2007 WO
2007050685 May 2007 WO
2009012336 Jan 2009 WO
2007050685 Apr 2009 WO
2011014201 Feb 2011 WO
2011019359 Feb 2011 WO
2011063816 Jun 2011 WO
2011079129 Jun 2011 WO
2011109393 Sep 2011 WO
2014165046 Oct 2014 WO
Non-Patent Literature Citations (86)
Entry
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Board Decision dated Jan. 22, 2019.
U.S. Appl. No. 15/669,697, filed Aug. 4, 2017 Non-Final Office Action dated Oct. 18, 2018.
“Tripartite Biocompatibility Guidance for Medical Devices,” DSMA (Apr. 24, 1987).
BR PI 0506836-3 filed Jan. 18, 2005, Technical Report dated Jul. 28, 2015.
CA 2,769,026 filed Jan. 24, 2012 First Examination Report dated Nov. 4, 2013.
CN 201080058895.4 filed Jun. 21, 2012 First Office Action dated Feb. 27, 2014.
CN 201080058895.4 filed Jun. 21, 2012 Second Office Action dated Nov. 3, 2014.
CN 201080058895.4 filed Jun. 21, 2012 Third Office Action dated May 4, 2015.
CN 201480013064.3 filed Sep. 8, 2015 Office Action dated Oct. 10, 2016.
EP 09848341.5 filed Feb. 27, 2012 extended European Search Report dated Apr. 4, 2013.
EP 09848341.5 filed Feb. 27, 2012 supplemental European Search Report dated Nov. 8, 2013.
EP 10840071.4 filed Jul. 4, 2012 Exam Report dated Apr. 29, 2014.
EP 10840071.4 filed Jul. 4, 2012 extended European Search Report dated Apr. 17, 2013.
EP 10840071.4 filed Jul. 4, 2012 Notice of Opposition dated Apr. 24, 2017.
EP 10840071.4 filed Jul. 4, 2012 Office Action dated Jul. 9, 2015.
EP 11751198.0 filed Sep. 28, 2012 Exam Report dated Feb. 7, 2014.
EP 11751198.0 filed Sep. 28, 2012 extended European search report dated Jul. 9, 2013.
EP 14779919.1 filed Sep. 10, 2015 Extended European Search Report dated Aug. 23, 2016.
EP 16171279.9 filed May 25, 2016 Extended European Search Report, dated Aug. 23, 2016.
JP 2012-546157 filed Jun. 12, 2012 Decision of Rejection dated Aug. 21, 2015.
JP 2012-546157 filed Jun. 12, 2012 First Office Action dated Sep. 16, 2014.
JP 2015-243156 filed Dec. 14, 2015 Office Action dated Sep. 16, 2016.
Norton, J.A. et al., Surgery: Basic Science and Clinical Evidence Springer, 2nd ed., 2008, p. 281.
PCT/US2006/041633 filed Oct. 25, 2006 International Preliminary Report on Patentability dated Mar. 24, 2009.
PCT/US2006/041633 filed Oct. 25, 2006 Search Report dated Aug. 12, 2008.
PCT/US2006/041633 filed Oct. 25, 2006 Written Opinion dated Aug. 12, 2008.
PCT/US2009/055389 filed Aug. 28, 2009 International Search Report dated Oct. 20, 2009.
PCT/US2009/055389 filed Aug. 28, 2009 Written Opinion dated Oct. 20, 2009.
PCT/US2009/055395 filed Aug. 28, 2009 International Preliminary Report on Patentability dated Jan. 31, 2012.
PCT/US2009/055395 filed Aug. 28, 2009 International Search Report dated Oct. 15, 2009.
PCT/US2009/055395 filed Aug. 28, 2009 Written Opinion dated Oct. 15, 2009.
PCT/US2010/061597 filed Dec. 21, 2010 International Preliminary Report on Patentability dated Jun. 26, 2012 and Written Opinion dated Feb. 28, 2011.
PCT/US2010/061597 filed Dec. 21, 2010 International Search Report dated Feb. 28, 2011.
PCT/US2011/026681 filed Mar. 1, 2011 International Preliminary Report on Patentability dated Sep. 4, 2012.
PCT/US2011/026681 filed Mar. 1, 2011 International Search Report dated Apr. 27, 2011.
PCT/US2011/026681 filed Mar. 1, 2011 Written Opinion dated Apr. 27, 2011.
PCT/US2014/024231 filed Mar. 12, 2014 International Search Report and Written Opinion dated Jul. 10, 2014.
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Final Office Action dated Sep. 22, 2011.
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Non-Final Office Action dated May 10, 2011.
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Non-Final Office Action dated Nov. 24, 2010.
U.S. Appl. No. 12/091,916, filed Feb. 2, 2009 Notice of Allowance dated Aug. 17, 2012.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Advisory Action dated Feb. 27, 2014.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Examiner's Answer dated Oct. 5, 2016.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Final Office Action dated Dec. 11, 2013.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Final Office Action dated Oct. 31, 2014.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Final Office Action dated Oct. 5, 2015.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Jan. 15, 2013.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Jul. 15, 2014.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Jun. 6, 2013.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Non-Final Office Action dated Mar. 12, 2015.
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Decision on Appeal dated Jun. 29, 2017.
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Examiner's Answer dated Aug. 27, 2015.
AU 2014248744 filed Jul. 9, 2015 Examiner's Report dated Jul. 26, 2017.
CN 201480013064.3 filed Sep. 8, 2015 Office Action dated Jun. 29, 2017.
EP 14779919.1 filed Sep. 10, 2015 Office Action dated Jul. 4, 2017.
EP 16171279.9 filed May 25, 2016 Intent to Grant, dated Jun. 13, 2017.
EP 17201044.9 filed Nov. 10, 2017 Extended European Search Report dated Jan. 18, 2018.
JP 2016-501444 filed Sep. 11, 2015 Office Action dated Dec. 14, 2017.
Mx/a/2015/009904 filed Jul. 30, 2015 Office Action dated Jun. 29, 2018.
RU 2015140616 filed Sep. 24, 2015 Office Action dated Feb. 21, 2018.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Notice of Allowance dated Jul. 30, 2018.
U.S. Appl. No. 13/387,447, filed Mar. 22, 2012 Patent Board Decision dated Jun. 1, 2018.
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Notice of Allowance dated Jul. 5, 2017.
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Examiner's Answre dated Nov. 22, 2017.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Board Decision dated Aug. 23, 2018.
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Final Office Action dated Dec. 10, 2014.
U.S. Appl. No. 13/389,753, filed Mar. 20, 2012 Non-Final Office Action dated Jul. 21, 2014.
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Advisory Action dated Sep. 22, 2016.
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Final Office Action dated Jun. 29, 2016.
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Non-Final Office Action dated Mar. 8, 2016.
U.S. Appl. No. 13/582,698, filed Sep. 4, 2012 Non-Final Office Action dated Sep. 24, 2014.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Examiner's Answer dated Jun. 2, 2017.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Final Office Action dated Feb. 20, 2015.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Final Office Action dated Oct. 19, 2016.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Non-Final Office Action dated Jul. 7, 2016.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Non-Final Office Action dated Sep. 12, 2014.
U.S. Appl. No. 13/662,278, filed Oct. 26, 2012 Non-Final Office Action dated Sep. 17, 2015.
U.S. Appl. No. 13/802,095, filed Mar. 13, 2013 Non-Final Office Action dated Aug. 15, 2014.
U.S. Appl. No. 13/802,095, filed Mar. 13, 2013 Notice of Allowance dated Nov. 28, 2014.
U.S. Appl. No. 14/681,023, filed Apr. 7, 2015 Non-Final Office Action dated Nov. 9, 2016.
U.S. Appl. No. 14/681,023, filed Apr. 7, 2015 Notice of Allowance dated Mar. 8, 2017.
U.S. Appl. No. 14/707,954, filed May 8, 2015 Non-Final Office Action dated Dec. 1, 2016.
EP 17201044.9 filed Nov. 10, 2017 Office Action dated Jul. 4, 2019.
Piyush Gupta et al. Hydrogels: from controlled release to pH-responsive drug delivery, May 2002, DDT vol. 7, No. 10, pp. 569-579. (Year 2002).
U.S. Appl. No. 13/516,660, filed Aug. 27, 2012 Non-Final Office Action dated Mar. 15, 2019.
U.S. Appl. No. 15/669,697, filed Aug. 4, 2017 Notice of Allowance dated Mar. 1, 2019.
Related Publications (1)
Number Date Country
20170296704 A1 Oct 2017 US
Continuations (2)
Number Date Country
Parent 14681023 Apr 2015 US
Child 15639844 US
Parent 13802095 Mar 2013 US
Child 14681023 US